Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy [NA]
The clinical trial evaluating remote ischemia pre-conditioning in patients undergoing partial nephrectomy for renal cell carcinoma was termi…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal [Phase 2]
Phase 2 trial evaluating pre-operative use of sorafenib in patients with metastatic renal cell carcinoma undergoing nephrectomy has complete…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]
ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma [Phase 2]
This clinical trial update indicates that a Phase 2 neoadjuvant study of Sutent (sunitinib) for renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) [NA]
This completed feasibility multicenter randomized trial compared surgery with needle ablation techniques for small renal masses (4 cm).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors [Phase 1]
Phase 1 safety study of recombinant vaccinia virus JX-594 for refractory solid tumors completed, evaluating melanoma, lung cancer, renal cel…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients [Phase 2]
Phase 2 trial update evaluating bevacizumab with an autologous tumor/dendritic cell vaccine plus interleukin-2 and interferon alfa-2b in met…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response [Phase 1]
This Phase 1 trial of Sunitinib in metastatic renal cell carcinoma evaluated imaging biomarkers to predict early tumor response during thera…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib for locally recurrent or metastatic kidney cancer. The study has completed and posted results in…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial of vorinostat and isotretinoin in advanced kidney cancer (recurrent/stage III/IV renal cell cancer) has been terminated with…
-
CLINICAL_TRIALS withdrawal · 2015-11-23Clinical Trial Update: Functional Imaging in the Assessment of mRCC Response to Sunitinib [NA]
A clinical trial evaluating functional imaging to assess metastatic renal cell carcinoma response to sunitinib has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) [Phase 1]
A Phase 1 study evaluating the combination of sunitinib and temsirolimus in renal cell carcinoma has been completed.
-
CLINICAL_TRIALS withdrawal · 2015-11-13Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery [Phase 1]
Phase 1 trial of peripheral stem cell transplantation for metastatic or unresectable cancers including breast cancer, renal cell carcinoma, …
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma [Phase 3]
A phase 3 trial comparing dovitinib with sorafenib in metastatic renal cell carcinoma has completed, with results posted in November 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Bioequivalence Study of Sorafenib Tablet and Nexavar [Phase 1]
A Phase 1 bioequivalence study comparing sorafenib tablet to Nexavar under fasting conditions has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
This completed trial assessed the vascular and metabolic effects of sunitinib in patients with metastatic renal cell carcinoma, focusing on …
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial update for BMS-936558 (MDX-1106) in advanced/metastatic clear-cell renal cell carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer [Phase 1]
A Phase 1 clinical trial evaluating the safety and immunologic response of COMBIG-DC in patients with metastatic renal cell carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study exploring trebananib in combination with temsirolimus for adults with metastatic or unresectable solid tumors, including neuro…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging
This clinical trial update reports on completed research evaluating whether functional imaging can predict response to anti-angiogenic thera…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating sorafenib in elderly patients with metastatic renal cell carcinoma, with the study subsequently terminated.
-
FDA approval · 2015-09-22FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) from Novartis Pharmaceuticals, signaling an update to the dru…
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: Regulatory Post Marketing Surveillance Study on Nexavar®
A completed regulatory post-marketing surveillance study evaluating Nexavar (sorafenib) safety in patients with hepatocellular carcinoma and…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating Velcade (bortezomib) with sorafenib in unresected or metastatic renal cell carcinoma was terminated; results were…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat in combination with bevacizumab for unresectable or metastatic renal cell carcinoma has completed with…